159 related articles for article (PubMed ID: 6388328)
21. Outpatient conversion of treatment to potassium-sparing diuretics.
Ridgeway NA; Ginn DR; Alley K
Am J Med; 1986 May; 80(5):785-8. PubMed ID: 3706365
[TBL] [Abstract][Full Text] [Related]
22. Absorption and disposition of two combination formulations of hydrochlorothiazide and triamterene: influence of age and renal function.
Williams RL; Thornhill MD; Upton RA; Blume C; Clark TS; Lin E; Benet LZ
Clin Pharmacol Ther; 1986 Aug; 40(2):226-32. PubMed ID: 3731685
[TBL] [Abstract][Full Text] [Related]
23. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
McClennen W; Wilson T
Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768
[TBL] [Abstract][Full Text] [Related]
24. Placebo-controlled trial of a combination of bemetizide and triamterene ('Hypertane') in mild or moderate hypertension.
Hornung R; Keiso H; Raftery EB; Whittington JR
Curr Med Res Opin; 1983; 8(6):425-33. PubMed ID: 6342957
[No Abstract] [Full Text] [Related]
25. The PACT study: post-marketing surveillance in 47,465 patients treated with Maxzide (triamterene/hydrochlorothiazide). An interim report.
Hollenberg NK; Bannon JA
Am J Med; 1986 Apr; 80(4A):30-6. PubMed ID: 3518430
[No Abstract] [Full Text] [Related]
26. Hydrochlorothiazide and spironolactone in hypertension.
Schrijver G; Weinberger MH
Clin Pharmacol Ther; 1979 Jan; 25(1):33-42. PubMed ID: 363334
[TBL] [Abstract][Full Text] [Related]
27. Antihypertensive therapy in patients above age 60 with systolic hypertension. A progress report of the European Working Party on High Blood Pressure in the Elderly (EWPHE).
Amery A; Birkenhäger W; Bogaert M; Brixko P; Bulpitt C; Clement D; De Leeuw P; De Plaen JF; Deruyttere M; De Schaepdryver A; Fagard R; Forette F; Forte J; Hamdy R; Hellemans J; Henry JF; Koistinen A; Laaser U; Laher M; Leonetti G; Lewis P; Lund-Johansen P; MacFarlane J; Meurer K; Miguel P; Morris J; Mutsers A; Nissinen A; O'Brien E; Ohm OJ; O'Malley K; Pelemans W; Perera N; Tuomilehto J; Verschueren LJ; Willemse P; Williams B; Zanchetti A
Clin Exp Hypertens A; 1982; 4(7):1151-76. PubMed ID: 7116662
[TBL] [Abstract][Full Text] [Related]
28. Antihypertensive and biochemical effects of different doses of hydrochlorothiazide alone or in combination with triamterene.
Kohvakka A; Salo H; Gordin A; Eisalo A
Acta Med Scand; 1986; 219(4):381-6. PubMed ID: 3521208
[TBL] [Abstract][Full Text] [Related]
29. A comparison of a hydrochlorothiazide plus triamterene combination (Dyazide) and atenolol in the treatment of patients with mild hypertension: a multicentre study in general practice.
Philip IG; Qureshi SM; Richards HH; Sharma SK; Wright FG; Young PH; Rowley-Jones D
Br J Clin Pract; 1987 Oct; 41(10):947-53. PubMed ID: 3333144
[No Abstract] [Full Text] [Related]
30. Treatment of mild-to-moderate hypertension: comparison between a calcium-channel blocker and a potassium-sparing diuretic.
Boulet AP; Chockalingam A; Fodor JG; Laplante L; Houde M; Lenis J; Logan AG; Robitaille MN; Ryan D; Spénard J
J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S45-50. PubMed ID: 1725543
[TBL] [Abstract][Full Text] [Related]
31. Double-blind comparison of triamterene plus hydrochlorothiazide and spironolactone plus hydrochlorothiazide in the treatment of hypertension.
Cocke TB; Fisch S; Gilmore HR; Okun R; Tamagna IG; Wipplinger K
J Clin Pharmacol; 1977; 17(5-6):334-8. PubMed ID: 323298
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the efficacy and safety of a hydrochlorothiazide to chlorthalidone medication change in veterans with hypertension.
Matthews KA; Brenner MJ; Brenner AC
Clin Ther; 2013 Sep; 35(9):1423-30. PubMed ID: 23993697
[TBL] [Abstract][Full Text] [Related]
33. Potassium-sparing effects of triamterene in the treatment of hypertension.
Spiekerman RE; Berge KG; Thurber DL; Gedge SW; McGuckin WF
Circulation; 1966 Sep; 34(3):524-31. PubMed ID: 5332122
[No Abstract] [Full Text] [Related]
34. Comparison of two combined diuretics in the treatment of essential hypertension.
Verhiest W; Baehre M; Volkers P
Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):342-5. PubMed ID: 2674028
[TBL] [Abstract][Full Text] [Related]
35. [Diuretic monotherapy in heart failure. Comparison of piretanide and hydrochlorothiazide-triamterene].
Gonska BD; Kreuzer H
Dtsch Med Wochenschr; 1985 Nov; 110(47):1812-6. PubMed ID: 3905326
[TBL] [Abstract][Full Text] [Related]
36. Hydrochlorothiazide in combination with potassium-sparing agents in the treatment of hypertension.
Dean S; Spencer-Mills L
Curr Med Res Opin; 1984; 9(5):287-9. PubMed ID: 6397330
[TBL] [Abstract][Full Text] [Related]
37. Antihypertensive therapy in elderly patients. Pilot trial of the European Working Party on High Blood Pressure in the Elderly.
Amery A; Berthaux P; Birkenhäger W; Bulpitt C; Clement D; De Shaepdryver A; Dollery C; Ernould H; Fagard R; Forette F; Hellemans J; Kho T; Lund-Johansen P; Meurice J; Pierquin L
Gerontology; 1977; 23(6):426-37. PubMed ID: 330322
[TBL] [Abstract][Full Text] [Related]
38. Ticrynafen and hydrochlorothiazide in hypertension.
Okun R; Beg M
Clin Pharmacol Ther; 1978 Jun; 23(6):703-11. PubMed ID: 348380
[TBL] [Abstract][Full Text] [Related]
39. Changes in blood pressure, serum potassium and electrolytes with a combination of triamterene and a low dose of chlorthalidone.
Hort JF; Wilkins HM
Curr Med Res Opin; 1991; 12(7):430-40. PubMed ID: 1778085
[TBL] [Abstract][Full Text] [Related]
40. Treating black hypertensives with capozide.
Katz LA; Cobbol C
Am J Hypertens; 1988 Jul; 1(3 Pt 3):224S-226S. PubMed ID: 3046629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
